Redmile Group, LLC sold $2.8M of Aprea Therapeutics, Inc.

10% owner

Sold$2,791,290

$5.58Price

500,000Shares

−22%Stake

What APRE did after the filing

Prices for APRE after this filing aren't in yet.

Traded Mon, Dec 28. Filed Tue, Feb 16, 4:11 PM ET, after the close. Not investment advice.